Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christine Ryan, M.D.

Concepts (130)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lymphoma, Mantle-Cell320242372.250 Why?
Leukemia, Lymphocytic, Chronic, B-Cell8202316401.940 Why?
Lymphoma, Large B-Cell, Diffuse3202314050.960 Why?
Pneumocystis carinii12020720.660 Why?
Neurotoxicity Syndromes120233010.660 Why?
Pneumonia, Pneumocystis120202420.620 Why?
Opportunistic Infections120203760.560 Why?
Proto-Oncogene Proteins c-bcl-22202314040.460 Why?
Protein Kinase Inhibitors5202456620.390 Why?
Antineoplastic Combined Chemotherapy Protocols92024117320.340 Why?
Immunotherapy, Adoptive3202414680.340 Why?
Antigens, CD19220234240.260 Why?
Pyrazoles1201620100.260 Why?
Antineoplastic Agents42024136300.250 Why?
Neoplasm, Residual2202210080.240 Why?
Pyrimidines1201630260.230 Why?
Hematopoietic Stem Cell Transplantation4201656670.230 Why?
Molecular Targeted Therapy3202428130.220 Why?
Isoantibodies220156740.190 Why?
Piperidines2202316560.190 Why?
Drug Resistance, Neoplasm4202453000.190 Why?
H-Y Antigen22015420.160 Why?
Graft vs Host Disease3201630260.160 Why?
Clinical Trials, Phase III as Topic120228580.150 Why?
Retreatment120195980.150 Why?
Cardiology Service, Hospital120192400.150 Why?
Recurrence2202384560.140 Why?
Multicenter Studies as Topic1202217020.140 Why?
Cyclophosphamide1202322190.140 Why?
Staurosporine320122410.140 Why?
Tissue Donors2201623340.130 Why?
Central Nervous System1202313330.130 Why?
Chimerism120161550.130 Why?
Lymphocyte Depletion120166020.120 Why?
Receptors, Antigen, T-Cell1202325490.120 Why?
Germinal Center120163800.110 Why?
Receptors, Antigen12013510.110 Why?
Disease Management1202425080.110 Why?
Humans2020247610980.110 Why?
Lymphoma, B-Cell120199380.100 Why?
Immunomodulation120165490.100 Why?
Withholding Treatment120166160.100 Why?
Patient Admission1201913650.100 Why?
Treatment Outcome62023646700.100 Why?
Th2 Cells1201610710.090 Why?
Adenine120169860.090 Why?
Transplantation, Homologous2201648220.090 Why?
Urea120124420.080 Why?
Academic Medical Centers1201927570.080 Why?
Prospective Studies22023544190.080 Why?
Thiophenes120125690.070 Why?
T-Lymphocytes22023102030.070 Why?
Randomized Controlled Trials as Topic12022102130.060 Why?
Lymph Nodes1201634610.060 Why?
Protein Kinases1201216070.060 Why?
Camptothecin320125910.060 Why?
Healthcare Disparities1201933520.060 Why?
B-Lymphocytes1201647440.050 Why?
Coronavirus Infections1202030940.050 Why?
Neoplasms32021221250.050 Why?
Pneumonia, Viral1202032160.050 Why?
bcl-X Protein120234100.050 Why?
Health Services Accessibility1201954270.050 Why?
Tumor Suppressor Protein p531201229140.050 Why?
Adult720232210830.050 Why?
Hematopoietic Stem Cells1201333880.050 Why?
Genes, p53220127130.040 Why?
Neoplasm Proteins1201235940.040 Why?
Apoptosis Regulatory Proteins1202311380.040 Why?
Male720243606750.040 Why?
Immunization, Passive120206170.040 Why?
Retrospective Studies22023806730.040 Why?
Heart Failure12019117010.030 Why?
Aged620201692660.030 Why?
Middle Aged720202208350.030 Why?
Breast Neoplasms22012209810.030 Why?
Cohort Studies12016414860.030 Why?
Gene Order120131680.030 Why?
Ribosomal Protein S612012710.030 Why?
Apoptosis2202394780.030 Why?
Cell Line, Tumor22023169470.030 Why?
Genes, cdc120121140.020 Why?
Genes, erbB-2120121620.020 Why?
Female820203924580.020 Why?
Anti-Inflammatory Agents1202018120.020 Why?
Lentivirus120135070.020 Why?
Transduction, Genetic120139000.020 Why?
Cytotoxicity, Immunologic1201313510.020 Why?
Myeloid Cells120138210.020 Why?
Antineoplastic Agents, Phytogenic120126200.020 Why?
Inpatients1201925450.020 Why?
Antiviral Agents1202030480.020 Why?
Health Status Disparities1201918460.020 Why?
Maximum Tolerated Dose120108830.020 Why?
Survival Analysis12020100830.020 Why?
Mice, Inbred NOD1201218220.020 Why?
Receptors, Progesterone1201211290.020 Why?
Mice, SCID1201226210.020 Why?
Boston1201993240.020 Why?
DNA, Neoplasm1201217430.020 Why?
RNA, Messenger12021127430.020 Why?
Leukocytes, Mononuclear1201218370.020 Why?
Time Factors22019399530.020 Why?
Patient Readmission1201932680.020 Why?
Aged, 80 and over22020589460.010 Why?
Killer Cells, Natural1201321940.010 Why?
Genetic Vectors1201333880.010 Why?
Receptors, Estrogen1201222080.010 Why?
Cell Cycle1201229260.010 Why?
Xenograft Model Antitumor Assays1201235910.010 Why?
Anemia1201215040.010 Why?
Flow Cytometry1201358700.010 Why?
Lymphocyte Activation1201354780.010 Why?
DNA Damage1201224430.010 Why?
Mice22023813240.010 Why?
Proteomics1201538360.010 Why?
Animals320231680830.010 Why?
Mice, Transgenic1201395180.010 Why?
Pandemics1202086630.010 Why?
Cell Line12013155420.010 Why?
Age Factors12015183850.010 Why?
Risk Assessment12019240130.010 Why?
Immunotherapy1201346420.010 Why?
Cell Differentiation12013115050.010 Why?
Prognosis12015296720.010 Why?
Disease Models, Animal12013182170.010 Why?
Risk Factors12019742190.010 Why?
Mutation12012300060.000 Why?
Adolescent12015882710.000 Why?
Young Adult12010591990.000 Why?
Ryan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (130)
Explore
_
Co-Authors (78)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.